Cannabis Law Report

AUGUST 10, 2021

The global chronic pain treatment market is predicted to progress at a CAGR of 6.5% from 2020 to 2030 and generate revenue of $151.7 billion in 2030. It is an honour and privilege to be in the position to use novel psychedelic treatments to solve the complex puzzle that is chronic pain. 2 Pain 1994 Apr;57(1):5-15.

Chronic Pain 105

Chronic Pain Clinical Trials Research and Development Events 105

Cannabis Law Report

JANUARY 9, 2022

Since 2014 when sales began in Colorado and Washington, legalization policies have provided states a new revenue stream to bolster budgets and fund important services and programs. Here’s what they say. Legalizing cannabis for adults has been a wise investment. As of December 2021, states reported a combined total of $10.4

Collective 52

Collective Policy Retail Programs 52

The Cannigma

OCTOBER 20, 2021

In a June, 2020 interview, a Swiss drug policy expert told Marijuana Business Daily that the scientific process behind the pilot program is expected to last five years, and that if everything goes as planned, the matter of full recreational cannabis legalization for adults could be debated by 2030. appeared first on The Cannigma.

Legalization 52

Legalization Decriminalization Patients Medicine 52

Cannabis Law Report

JUNE 24, 2021

Policy Implications. More investment is needed for research into the harm that the non-medical use of cannabis poses to health and to better define the range of health conditions for which cannabis products may be an effective treatment. Drug Use Rising, but Science-Based Treatment More Available. The Dark Web.

Research and Development 99

Research and Development Supply Chain Pharmaceutical Treatment 99

Cannabis Law Report

JUNE 7, 2021

Since 2014, when sales began in Colorado and Washington, legalization policies have provided states a new revenue stream to bolster budgets and fund important services and programs. Legalizing marijuana for adults has been a wise investment. As of May 2021, states reported a combined total of $7.9 The state’s medical patients (about 0.5%

Marijuana 91

Marijuana Retail Collective Programs 91

The Joint Blog

JULY 30, 2020

They are the ones that see how the patients take to medication and treatment plans, and are the ones that deal directly with those in pain. They can advocate for their patients because they have seen how certain treatments, care plans, and legislative policies impact people on the grand scale.

Legislation 26

Legislation Policy Patients Treatment 26